新型コロナウイルス感染症抗原自己検査の世界市場インサイト・予測(~2028年)

【英語タイトル】Global COVID-19 Antigen Self Test Market Insights, Forecast to 2028

QYResearchが出版した調査資料(QY22JL3787)・商品コード:QY22JL3787
・発行会社(調査会社):QYResearch
・発行日:2022年7月
・ページ数:113
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:新技術
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

COVID-19のパンデミックにより、新型コロナウイルス感染症抗原自己検査のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に新型コロナウイルス感染症抗原自己検査の世界市場のxxx%を占める「1回分」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「オンライン」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
新型コロナウイルス感染症抗原自己検査の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパの新型コロナウイルス感染症抗原自己検査市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

新型コロナウイルス感染症抗原自己検査のグローバル主要企業には、Abbott、Siemens Healthcare、Intrivo、Mylab、QuickVue、iHealth、BD Veritor、InteliSwab、Ellume、Clinitest、Celltrion、ACON LABS、Guangzhou Wondfo Biotech、BGI、Vazyme、Hotgen、Lepu Medicalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

新型コロナウイルス感染症抗原自己検査市場は、種類と用途によって区分されます。世界の新型コロナウイルス感染症抗原自己検査市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
1回分、25回分、その他

【用途別セグメント】
オンライン、オフライン

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 新型コロナウイルス感染症抗原自己検査製品概要
- 種類別市場(1回分、25回分、その他)
- 用途別市場(オンライン、オフライン)
- 調査の目的
・エグゼクティブサマリー
- 世界の新型コロナウイルス感染症抗原自己検査販売量予測2017-2028
- 世界の新型コロナウイルス感染症抗原自己検査売上予測2017-2028
- 新型コロナウイルス感染症抗原自己検査の地域別販売量
- 新型コロナウイルス感染症抗原自己検査の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別新型コロナウイルス感染症抗原自己検査販売量
- 主要メーカー別新型コロナウイルス感染症抗原自己検査売上
- 主要メーカー別新型コロナウイルス感染症抗原自己検査価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(1回分、25回分、その他)
- 新型コロナウイルス感染症抗原自己検査の種類別販売量
- 新型コロナウイルス感染症抗原自己検査の種類別売上
- 新型コロナウイルス感染症抗原自己検査の種類別価格
・用途別市場規模(オンライン、オフライン)
- 新型コロナウイルス感染症抗原自己検査の用途別販売量
- 新型コロナウイルス感染症抗原自己検査の用途別売上
- 新型コロナウイルス感染症抗原自己検査の用途別価格
・北米市場
- 北米の新型コロナウイルス感染症抗原自己検査市場規模(種類別、用途別)
- 主要国別の新型コロナウイルス感染症抗原自己検査市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの新型コロナウイルス感染症抗原自己検査市場規模(種類別、用途別)
- 主要国別の新型コロナウイルス感染症抗原自己検査市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の新型コロナウイルス感染症抗原自己検査市場規模(種類別、用途別)
- 主要国別の新型コロナウイルス感染症抗原自己検査市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の新型コロナウイルス感染症抗原自己検査市場規模(種類別、用途別)
- 主要国別の新型コロナウイルス感染症抗原自己検査市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの新型コロナウイルス感染症抗原自己検査市場規模(種類別、用途別)
- 主要国別の新型コロナウイルス感染症抗原自己検査市場規模(トルコ、サウジアラビア)
・企業情報
Abbott、Siemens Healthcare、Intrivo、Mylab、QuickVue、iHealth、BD Veritor、InteliSwab、Ellume、Clinitest、Celltrion、ACON LABS、Guangzhou Wondfo Biotech、BGI、Vazyme、Hotgen、Lepu Medical
・産業チェーン及び販売チャネル分析
- 新型コロナウイルス感染症抗原自己検査の産業チェーン分析
- 新型コロナウイルス感染症抗原自己検査の原材料
- 新型コロナウイルス感染症抗原自己検査の生産プロセス
- 新型コロナウイルス感染症抗原自己検査の販売及びマーケティング
- 新型コロナウイルス感染症抗原自己検査の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 新型コロナウイルス感染症抗原自己検査の産業動向
- 新型コロナウイルス感染症抗原自己検査のマーケットドライバー
- 新型コロナウイルス感染症抗原自己検査の課題
- 新型コロナウイルス感染症抗原自己検査の阻害要因
・主な調査結果

Market Analysis and Insights: Global COVID-19 Antigen Self Test Market
Due to the COVID-19 pandemic, the global COVID-19 Antigen Self Test market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 1 Serving accounting for % of the COVID-19 Antigen Self Test global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Online segment is altered to an % CAGR throughout this forecast period.
China COVID-19 Antigen Self Test market size is valued at US$ million in 2021, while the US and Europe COVID-19 Antigen Self Test are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe COVID-19 Antigen Self Test landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of COVID-19 Antigen Self Test include Abbott, Siemens Healthcare, Intrivo, Mylab, QuickVue, iHealth, BD Veritor, InteliSwab and Ellume, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global COVID-19 Antigen Self Test Scope and Segment
COVID-19 Antigen Self Test market is segmented by Type and by Channel. Players, stakeholders, and other participants in the global COVID-19 Antigen Self Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Channel for the period 2017-2028.
Segment by Type
1 Serving
25 Servings
Other
Segment by Channel
Online
Offline
By Company
Abbott
Siemens Healthcare
Intrivo
Mylab
QuickVue
iHealth
BD Veritor
InteliSwab
Ellume
Clinitest
Celltrion
ACON LABS
Guangzhou Wondfo Biotech
BGI
Vazyme
Hotgen
Lepu Medical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 COVID-19 Antigen Self Test Product Introduction
1.2 Market by Type
1.2.1 Global COVID-19 Antigen Self Test Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 1 Serving
1.2.3 25 Servings
1.2.4 Other
1.3 Market by Channel
1.3.1 Global COVID-19 Antigen Self Test Market Size Growth Rate by Channel, 2017 VS 2021 VS 2028
1.3.2 Online
1.3.3 Offline
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global COVID-19 Antigen Self Test Sales Estimates and Forecasts 2017-2028
2.2 Global COVID-19 Antigen Self Test Revenue Estimates and Forecasts 2017-2028
2.3 Global COVID-19 Antigen Self Test Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global COVID-19 Antigen Self Test Sales by Region
2.4.1 Global COVID-19 Antigen Self Test Sales by Region (2017-2022)
2.4.2 Global Sales COVID-19 Antigen Self Test by Region (2023-2028)
2.5 Global COVID-19 Antigen Self Test Revenue by Region
2.5.1 Global COVID-19 Antigen Self Test Revenue by Region (2017-2022)
2.5.2 Global COVID-19 Antigen Self Test Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global COVID-19 Antigen Self Test Sales by Manufacturers
3.1.1 Global Top COVID-19 Antigen Self Test Manufacturers by Sales (2017-2022)
3.1.2 Global COVID-19 Antigen Self Test Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of COVID-19 Antigen Self Test in 2021
3.2 Global COVID-19 Antigen Self Test Revenue by Manufacturers
3.2.1 Global COVID-19 Antigen Self Test Revenue by Manufacturers (2017-2022)
3.2.2 Global COVID-19 Antigen Self Test Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by COVID-19 Antigen Self Test Revenue in 2021
3.3 Global COVID-19 Antigen Self Test Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global COVID-19 Antigen Self Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global COVID-19 Antigen Self Test Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global COVID-19 Antigen Self Test Sales by Type
4.1.1 Global COVID-19 Antigen Self Test Historical Sales by Type (2017-2022)
4.1.2 Global COVID-19 Antigen Self Test Forecasted Sales by Type (2023-2028)
4.1.3 Global COVID-19 Antigen Self Test Sales Market Share by Type (2017-2028)
4.2 Global COVID-19 Antigen Self Test Revenue by Type
4.2.1 Global COVID-19 Antigen Self Test Historical Revenue by Type (2017-2022)
4.2.2 Global COVID-19 Antigen Self Test Forecasted Revenue by Type (2023-2028)
4.2.3 Global COVID-19 Antigen Self Test Revenue Market Share by Type (2017-2028)
4.3 Global COVID-19 Antigen Self Test Price by Type
4.3.1 Global COVID-19 Antigen Self Test Price by Type (2017-2022)
4.3.2 Global COVID-19 Antigen Self Test Price Forecast by Type (2023-2028)
5 Market Size by Channel
5.1 Global COVID-19 Antigen Self Test Sales by Channel
5.1.1 Global COVID-19 Antigen Self Test Historical Sales by Channel (2017-2022)
5.1.2 Global COVID-19 Antigen Self Test Forecasted Sales by Channel (2023-2028)
5.1.3 Global COVID-19 Antigen Self Test Sales Market Share by Channel (2017-2028)
5.2 Global COVID-19 Antigen Self Test Revenue by Channel
5.2.1 Global COVID-19 Antigen Self Test Historical Revenue by Channel (2017-2022)
5.2.2 Global COVID-19 Antigen Self Test Forecasted Revenue by Channel (2023-2028)
5.2.3 Global COVID-19 Antigen Self Test Revenue Market Share by Channel (2017-2028)
5.3 Global COVID-19 Antigen Self Test Price by Channel
5.3.1 Global COVID-19 Antigen Self Test Price by Channel (2017-2022)
5.3.2 Global COVID-19 Antigen Self Test Price Forecast by Channel (2023-2028)
6 North America
6.1 North America COVID-19 Antigen Self Test Market Size by Type
6.1.1 North America COVID-19 Antigen Self Test Sales by Type (2017-2028)
6.1.2 North America COVID-19 Antigen Self Test Revenue by Type (2017-2028)
6.2 North America COVID-19 Antigen Self Test Market Size by Channel
6.2.1 North America COVID-19 Antigen Self Test Sales by Channel (2017-2028)
6.2.2 North America COVID-19 Antigen Self Test Revenue by Channel (2017-2028)
6.3 North America COVID-19 Antigen Self Test Market Size by Country
6.3.1 North America COVID-19 Antigen Self Test Sales by Country (2017-2028)
6.3.2 North America COVID-19 Antigen Self Test Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe COVID-19 Antigen Self Test Market Size by Type
7.1.1 Europe COVID-19 Antigen Self Test Sales by Type (2017-2028)
7.1.2 Europe COVID-19 Antigen Self Test Revenue by Type (2017-2028)
7.2 Europe COVID-19 Antigen Self Test Market Size by Channel
7.2.1 Europe COVID-19 Antigen Self Test Sales by Channel (2017-2028)
7.2.2 Europe COVID-19 Antigen Self Test Revenue by Channel (2017-2028)
7.3 Europe COVID-19 Antigen Self Test Market Size by Country
7.3.1 Europe COVID-19 Antigen Self Test Sales by Country (2017-2028)
7.3.2 Europe COVID-19 Antigen Self Test Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific COVID-19 Antigen Self Test Market Size by Type
8.1.1 Asia Pacific COVID-19 Antigen Self Test Sales by Type (2017-2028)
8.1.2 Asia Pacific COVID-19 Antigen Self Test Revenue by Type (2017-2028)
8.2 Asia Pacific COVID-19 Antigen Self Test Market Size by Channel
8.2.1 Asia Pacific COVID-19 Antigen Self Test Sales by Channel (2017-2028)
8.2.2 Asia Pacific COVID-19 Antigen Self Test Revenue by Channel (2017-2028)
8.3 Asia Pacific COVID-19 Antigen Self Test Market Size by Region
8.3.1 Asia Pacific COVID-19 Antigen Self Test Sales by Region (2017-2028)
8.3.2 Asia Pacific COVID-19 Antigen Self Test Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America COVID-19 Antigen Self Test Market Size by Type
9.1.1 Latin America COVID-19 Antigen Self Test Sales by Type (2017-2028)
9.1.2 Latin America COVID-19 Antigen Self Test Revenue by Type (2017-2028)
9.2 Latin America COVID-19 Antigen Self Test Market Size by Channel
9.2.1 Latin America COVID-19 Antigen Self Test Sales by Channel (2017-2028)
9.2.2 Latin America COVID-19 Antigen Self Test Revenue by Channel (2017-2028)
9.3 Latin America COVID-19 Antigen Self Test Market Size by Country
9.3.1 Latin America COVID-19 Antigen Self Test Sales by Country (2017-2028)
9.3.2 Latin America COVID-19 Antigen Self Test Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa COVID-19 Antigen Self Test Market Size by Type
10.1.1 Middle East and Africa COVID-19 Antigen Self Test Sales by Type (2017-2028)
10.1.2 Middle East and Africa COVID-19 Antigen Self Test Revenue by Type (2017-2028)
10.2 Middle East and Africa COVID-19 Antigen Self Test Market Size by Channel
10.2.1 Middle East and Africa COVID-19 Antigen Self Test Sales by Channel (2017-2028)
10.2.2 Middle East and Africa COVID-19 Antigen Self Test Revenue by Channel (2017-2028)
10.3 Middle East and Africa COVID-19 Antigen Self Test Market Size by Country
10.3.1 Middle East and Africa COVID-19 Antigen Self Test Sales by Country (2017-2028)
10.3.2 Middle East and Africa COVID-19 Antigen Self Test Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Overview
11.1.3 Abbott COVID-19 Antigen Self Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Abbott COVID-19 Antigen Self Test Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbott Recent Developments
11.2 Siemens Healthcare
11.2.1 Siemens Healthcare Corporation Information
11.2.2 Siemens Healthcare Overview
11.2.3 Siemens Healthcare COVID-19 Antigen Self Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Siemens Healthcare COVID-19 Antigen Self Test Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Siemens Healthcare Recent Developments
11.3 Intrivo
11.3.1 Intrivo Corporation Information
11.3.2 Intrivo Overview
11.3.3 Intrivo COVID-19 Antigen Self Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Intrivo COVID-19 Antigen Self Test Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Intrivo Recent Developments
11.4 Mylab
11.4.1 Mylab Corporation Information
11.4.2 Mylab Overview
11.4.3 Mylab COVID-19 Antigen Self Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Mylab COVID-19 Antigen Self Test Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylab Recent Developments
11.5 QuickVue
11.5.1 QuickVue Corporation Information
11.5.2 QuickVue Overview
11.5.3 QuickVue COVID-19 Antigen Self Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 QuickVue COVID-19 Antigen Self Test Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 QuickVue Recent Developments
11.6 iHealth
11.6.1 iHealth Corporation Information
11.6.2 iHealth Overview
11.6.3 iHealth COVID-19 Antigen Self Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 iHealth COVID-19 Antigen Self Test Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 iHealth Recent Developments
11.7 BD Veritor
11.7.1 BD Veritor Corporation Information
11.7.2 BD Veritor Overview
11.7.3 BD Veritor COVID-19 Antigen Self Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 BD Veritor COVID-19 Antigen Self Test Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 BD Veritor Recent Developments
11.8 InteliSwab
11.8.1 InteliSwab Corporation Information
11.8.2 InteliSwab Overview
11.8.3 InteliSwab COVID-19 Antigen Self Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 InteliSwab COVID-19 Antigen Self Test Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 InteliSwab Recent Developments
11.9 Ellume
11.9.1 Ellume Corporation Information
11.9.2 Ellume Overview
11.9.3 Ellume COVID-19 Antigen Self Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Ellume COVID-19 Antigen Self Test Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Ellume Recent Developments
11.10 Clinitest
11.10.1 Clinitest Corporation Information
11.10.2 Clinitest Overview
11.10.3 Clinitest COVID-19 Antigen Self Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Clinitest COVID-19 Antigen Self Test Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Clinitest Recent Developments
11.11 Celltrion
11.11.1 Celltrion Corporation Information
11.11.2 Celltrion Overview
11.11.3 Celltrion COVID-19 Antigen Self Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Celltrion COVID-19 Antigen Self Test Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Celltrion Recent Developments
11.12 ACON LABS
11.12.1 ACON LABS Corporation Information
11.12.2 ACON LABS Overview
11.12.3 ACON LABS COVID-19 Antigen Self Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 ACON LABS COVID-19 Antigen Self Test Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 ACON LABS Recent Developments
11.13 Guangzhou Wondfo Biotech
11.13.1 Guangzhou Wondfo Biotech Corporation Information
11.13.2 Guangzhou Wondfo Biotech Overview
11.13.3 Guangzhou Wondfo Biotech COVID-19 Antigen Self Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Guangzhou Wondfo Biotech COVID-19 Antigen Self Test Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Guangzhou Wondfo Biotech Recent Developments
11.14 BGI
11.14.1 BGI Corporation Information
11.14.2 BGI Overview
11.14.3 BGI COVID-19 Antigen Self Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 BGI COVID-19 Antigen Self Test Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 BGI Recent Developments
11.15 Vazyme
11.15.1 Vazyme Corporation Information
11.15.2 Vazyme Overview
11.15.3 Vazyme COVID-19 Antigen Self Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Vazyme COVID-19 Antigen Self Test Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Vazyme Recent Developments
11.16 Hotgen
11.16.1 Hotgen Corporation Information
11.16.2 Hotgen Overview
11.16.3 Hotgen COVID-19 Antigen Self Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Hotgen COVID-19 Antigen Self Test Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Hotgen Recent Developments
11.17 Lepu Medical
11.17.1 Lepu Medical Corporation Information
11.17.2 Lepu Medical Overview
11.17.3 Lepu Medical COVID-19 Antigen Self Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Lepu Medical COVID-19 Antigen Self Test Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Lepu Medical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 COVID-19 Antigen Self Test Industry Chain Analysis
12.2 COVID-19 Antigen Self Test Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 COVID-19 Antigen Self Test Production Mode & Process
12.4 COVID-19 Antigen Self Test Sales and Marketing
12.4.1 COVID-19 Antigen Self Test Sales Channels
12.4.2 COVID-19 Antigen Self Test Distributors
12.5 COVID-19 Antigen Self Test Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 COVID-19 Antigen Self Test Industry Trends
13.2 COVID-19 Antigen Self Test Market Drivers
13.3 COVID-19 Antigen Self Test Market Challenges
13.4 COVID-19 Antigen Self Test Market Restraints
14 Key Findings in The Global COVID-19 Antigen Self Test Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer



★調査レポート[新型コロナウイルス感染症抗原自己検査の世界市場インサイト・予測(~2028年)] (コード:QY22JL3787)販売に関する免責事項を必ずご確認ください。
★調査レポート[新型コロナウイルス感染症抗原自己検査の世界市場インサイト・予測(~2028年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆